Ultragenyx Pharmaceutical Inc. Common Stock (RARE)

Typically moves ±5.44% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-11-04 ESTIMATED

Since Aug 02, 2021, Ultragenyx Pharmaceutical Inc. Common Stock (RARE) has reported earnings 21 times. On average the shares move ±5.44% post-earnings, with a positive reaction 47.6% of the time. Its largest post-earnings gain was +14.2% (Aug 01, 2024) and its largest decline was -13.51% (May 05, 2022). The next earnings report is predicted for 2026-11-04 (estimated).

Earnings reactions

How RARE moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±5.44%

Positive %

47.6%

Negative %

52.4%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 04, 2026	☽ POST	-3.45%	open_in_new
May 05, 2026	☽ POST	+3.68%	open_in_new
Feb 12, 2026	☽ POST	-12.78%	open_in_new
Nov 04, 2025	☽ POST	-1.54%	open_in_new
Aug 05, 2025	☽ POST	-2.87%	open_in_new
May 06, 2025	☽ POST	-4.74%	open_in_new
Feb 13, 2025	☽ POST	-2.27%	open_in_new
Nov 05, 2024	☽ POST	-3.2%	open_in_new
Aug 01, 2024	☽ POST	+14.2%	open_in_new
May 02, 2024	☽ POST	-1.06%	open_in_new
Feb 15, 2024	☽ POST	+6%	open_in_new
Nov 02, 2023	☽ POST	+6.15%	open_in_new
Aug 03, 2023	☽ POST	-8.75%	open_in_new
May 04, 2023	☽ POST	+3.12%	open_in_new
Feb 16, 2023	☽ POST	+9.87%	open_in_new
Nov 02, 2022	☽ POST	-5.94%	open_in_new
Jul 28, 2022	☽ POST	+3.17%	open_in_new
May 05, 2022	☽ POST	-13.51%	open_in_new
Feb 10, 2022	☽ POST	+2.63%	open_in_new
Nov 02, 2021	☽ POST	+1.55%	open_in_new
Aug 02, 2021	☽ POST	+3.83%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±5.44%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 3 →

Funds holding

$1108074

Total value held

Buying

3 added · 0 reduced

Allstate Corp

$1096594 NEW BUY

Zions Bancorporation, National Association /Ut/

$10451 NEW BUY

Amalgamated Financial Corp.

$1029 NEW BUY

SEC Filing Types

description SCHEDULE 13G

4 chevron_right

description SCHEDULE 13G/A

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260908	open_in_new SEC.gov
8-K	20260902	open_in_new SEC.gov
8-K	20260819	open_in_new SEC.gov
SCHEDULE 13G	20260814	open_in_new SEC.gov
SCHEDULE 13G	20260813	open_in_new SEC.gov
8-K	20260811	open_in_new SEC.gov
SCHEDULE 13G	20260807	open_in_new SEC.gov
10-Q	20260805	open_in_new SEC.gov
4	20260804	open_in_new SEC.gov
4	20260804	open_in_new SEC.gov

Frequently asked about RARE earnings

When does Ultragenyx Pharmaceutical Inc. Common Stock report earnings next? expand_more

Ultragenyx Pharmaceutical Inc. Common Stock (RARE)'s next earnings date is estimated for 2026-11-04. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does RARE stock move after earnings? expand_more

Over 21 reports, RARE has moved an average of ±5.44% the session after earnings, closing higher 47.6% of the time.

What was RARE's biggest post-earnings move? expand_more

RARE's largest post-earnings gain on record was +14.2% on Aug 01, 2024, and its largest decline was -13.51% on May 05, 2022.

Where can I find Ultragenyx Pharmaceutical Inc. Common Stock's SEC filings? expand_more

All of Ultragenyx Pharmaceutical Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.